Analysis of the acidity index and integrated intragastric acidity in 645 patients presenting with gastroesophageal reflux disease symptoms

References

• Hunt RH. The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995; 9 Suppl 1: 3–7
   PubMedGoogle Scholar
• Dent J. Gastro-esophageal reflux disease. Digestion 1998; 59: 433–45
   PubMedGoogle Scholar
• Bell NJV, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastroesophageal reflux disease. Digestion 1992; 51 Suppl 1: 59–67
   PubMedGoogle Scholar
• Tutuian R, Castell DO, Xue S, Katz PO. The acidity index: a simple approach to the measurement of gastric acidity. Aliment Pharmacol Ther 2004; 19: 443–8
   PubMedGoogle Scholar
• Gardner JD, Rodriguez-Stanley S, Robinson M. Integrated acidity and the pathophysiology of gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 1363–70
   PubMed Web of Science ®Google Scholar
• Shih GL, Brensinger C, Katzka DA, Metz DC. Influence of age and gender on gastric acid secretion as estimated by integrated acidity in patients referred for 24-hour ambulatory pH monitoring. Am J Gastroenterol 2003; 98: 1713–8
   PubMedGoogle Scholar
• Pounder RE, Fraser AG. Gastric acid secretion and intragastric acidity: measurement in health and disease. Bailliere's Clin Gastroenterol 1993; 7: 55–80
   PubMedGoogle Scholar
• Gardner JD, Perdomo C, Sloan S, Hahne WF, Bath JA, Rodriguez-Stanley S, et al. Integrated acidity and rabeprazole pharmacology. Aliment Pharmacol Ther 2002; 16: 455–64
   PubMedGoogle Scholar
• Janczewska I, Sagar M, Sjostedt, Hammarland B, Iwarson M, Seensalu R. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33: 1239–43
   PubMed Web of Science ®Google Scholar
• Williams MP, Sercombe J, Hamilton MI, Pounder RE. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. Aliment Pharmacol Ther 1998; 12: 1079–89
   PubMed Web of Science ®Google Scholar
• Gardner JD, Sloan S, Miner PB, Robinson M. Meal-stimulated gastric acid secretion and integrated acidity in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003; 17: 945–53
   PubMed Web of Science ®Google Scholar
• Gardner JD, Sloan S, Miner PB, Robinson M. Determination of the reduction in the gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastro-oesophageal reflux disease treated with a proton pump inhibitor. Aliment Pharmacol Ther 2003; 17: 955–64
   PubMedGoogle Scholar
• Robinson M, Rodriguez-Stanley S, Ciociola AA, Filinto J, Zubaidi S, Miner PB, et al. Synergy between low-dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal-induced heartburn. Aliment Pharmacol Ther 2001; 15: 1365–74
   PubMedGoogle Scholar
• Shih G, Brensinger C, Katzka D, Metz DC. Postprandial esophageal integrated acidity is a reliable predictor of GERD. Aliment Pharmacol Therap 2005; 21: 1475–82
   PubMedGoogle Scholar
• Hirschowitz BI. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 1991; 101: 1149–58
   PubMed Web of Science ®Google Scholar
• Johansson KE, Ask P, Boeryd B, Fransson SG, Tibbling L. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986; 21: 837–47
   PubMed Web of Science ®Google Scholar
• Matikainen M. Gastric acid secretion, oesophageal acid reflux, and oesophagitis in patients with symptomatic gastro-oesophageal reflux. Scand J Gastroenterol 1981; 16: 1043–8
   PubMed Web of Science ®Google Scholar
• Collen MJ, Johnson DA, Sheridan MJ. Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy. Dig Dis Sci 1994; 39: 410–7
   PubMed Web of Science ®Google Scholar
• Collen MJ, Lewis JH, Benjamin SB. Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology 1990; 98: 654–61
   PubMed Web of Science ®Google Scholar
• Collen MJ, Strong RM. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion. Dig Dis Sci 1992; 37: 897–903
   PubMed Web of Science ®Google Scholar
• Waldum HL, Arnestad JS, Brenna E, Eide I, Syversen U, Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996; 39: 649–53
   PubMed Web of Science ®Google Scholar